Literature DB >> 12680892

Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population.

Akihiro Ishiguro, Takahiro Kubota, Hiroshi Sasaki, Yasuhiko Yamada, Tatsuji Iga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12680892      PMCID： PMC1884234          DOI： 10.1046/j.1365-2125.2003.01782.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype.

Authors:  M Chida; T Yokoi; N Nemoto; M Inaba; M Kinoshita; T Kamataki
Journal:  Pharmacogenetics       Date:  1999-06

2.  Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.

Authors:  T Kubota; Y Yamaura; N Ohkawa; H Hara; K Chiba
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

3.  CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.

Authors:  Y Nishida; T Fukuda; I Yamamoto; J Azuma
Journal:  Pharmacogenetics       Date:  2000-08

4.  Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.

Authors:  Yoshiharu Mitsunaga; Takahiro Kubota; Akihiro Ishiguro; Yasuhiko Yamada; Hiroshi Sasaki; Kan Chiba; Tatsuji Iga
Journal:  Mutat Res       Date:  2002-08-29       Impact factor: 2.433

5.  CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.

Authors:  J B Leathart; S J London; A Steward; J D Adams; J R Idle; A K Daly
Journal:  Pharmacogenetics       Date:  1998-12

6.  A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype.

Authors:  T Yokoi; Y Kosaka; M Chida; K Chiba; H Nakamura; T Ishizaki; M Kinoshita; K Sato; F J Gonzalez; T Kamataki
Journal:  Pharmacogenetics       Date:  1996-10

7.  Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

Authors:  I Johansson; M Oscarson; Q Y Yue; L Bertilsson; F Sjöqvist; M Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436
  7 in total
  3 in total

Review 1.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

2.  Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.

Authors:  Ali Bagheri; Behnam Kamalidehghan; Maryam Haghshenas; Parisa Azadfar; Leila Akbari; Mohammad Hossein Sangtarash; Faramarz Vejdandoust; Fatemeh Ahmadipour; Goh Yong Meng; Massoud Houshmand
Journal:  Drug Des Devel Ther       Date:  2015-05-13       Impact factor: 4.162

3.  Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.

Authors:  Kanokpich Puaprasert; Cindy Chu; Naowarat Saralamba; Nicholas P J Day; Francois Nosten; Nicholas J White; Arjen M Dondorp; Mallika Imwong
Journal:  Malar J       Date:  2018-11-15       Impact factor: 2.979
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.